Bublitz, Sarah K. http://orcid.org/0000-0003-3258-543X
Brandstötter, Cornelia
Fegg, Martin
Ferreira, Joaquim J.
Odin, Per
Bloem, Bastiaan R.
Meissner, Wassilios G.
Dodel, Richard
Schrag, Anette
Lorenzl, Stefan
Funding for this research was provided by:
EU Joint Programme – Neurodegenerative Disease Research (ES/L009250/1, HC-559-002, 01ED1403A, 01ED1403B, ANR-13-JPHC-0001-07, HC/0002/2012, 733051003)
Paracelsus Medical University
Article History
Accepted: 13 November 2023
First Online: 5 December 2023
Declarations
:
: Authors S.K.B, C.B. and M.F. declare they have no financial interests. J.J.F. has held consultancy functions with Abbvie, BIAL, NeuroDerm, Zambon, Sunovion, Affiris, and ONO Pharmaceutical Co., Ltd; has received lecture fees from BIAL, Sunovion, ONO, Zambon, and Abbvie; and has received grants from Novartis, Fundaçao Merck Sharp & Dohme (MSD, Portugal), and Medtronic. P.O. has received honoraria for lectures and expert advice from AbbVie, BIAL, Britannia, Global Kinetics, Lobsor, Nordic Infucare, PD Neurotechnology, and Zambon. B.R.B. has received honoraria from serving on the scientific advisory board for Zambon, Biogen, UCB, and Walk with Path; has received fees for speaking at conferences from AbbVie, Zambon, Roche, GE Healthcare, and BIAL; and has received research support from the Netherlands Organization for Scientific Research, The Michael J. Fox Foundation, UCB, Abbie, Zambon, the Stichting Parkinson Fonds, the Hersenstichting Nederland, the Parkinson’s Foundation, Verily Life Sciences, Horizon 2020, the Topsector Life Sciences and Health, and the Parkinson Vereniging. W.G.M. has received fees for editorial activities with Elsevier, and has served as advisor for Lundbeck, Biohaven, Takeda, Servier, Roche, Alterity, Inhibikase, and TEVA. R.D. has no additional disclosures to report. A.S. was supported by research funding or support from University College London, National Institute of Health, National Institute for Health Research University College London Hospital (ULCH) Biomedical Research Centre, the International Parkinson and Movement Disorder Society, the European Commission, Parkinson’s UK, GE Healthcare, and the Economic and Social Research Council; honoraria for consultancies from Abbvie and BIAL. S.L. has received honoraria for lectures from UCB and AbbVie.